CJC-1295 + Ipamorelin for Body Recomposition: Protocol
CJC-1295 and Ipamorelin for body recomposition work through synchronized pulsatile growth hormone release: CJC-1295 extends endogenous GHRH half-life from 7 minutes to 6–8 days via drug affinity complex (DAC) binding to serum albumin, while Ipamorelin selectively stimulates ghrelin receptors at the pituitary without elevating cortisol or prolactin. The combination produces GH pulses 3–5x baseline amplitude, … Read more